Fachrepositorium Lebenswissenschaften

13 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer

2024 . Uhlenbruch, Mark | Krüger, Stefan

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed

2024 . de Rouw, N. | Beunders, R. | Hartmann, O. | Schulte, J. | Boosman, R. J. | Derijks, H. J. | Burger, D. M. | van den Heuvel, M. M. | Hilbrands, L. B. | Pickkers, P. | ter Heine, R.

KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma

Age differences in the treatment of lung cancer–a cohort study among 42,000 patients from Germany

2024 . Rischke, Nikolaj | Kanbach, Josephine | Haug, Ulrike

Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma

2024 . Demir, Salih | Hotes, Alina | Schmid, Tanja | Cairo, Stefano | Indersie, Emilie | Pisano, Claudio | Hiyama, Eiso | Hishiki, Tomoro | Vokuhl, Christian | Branchereau, Sophie | Brock, Penelope | Schmid, Irene | Zsiros, József | Kappler, Roland

Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients

2021 . Purde, Mette-Triin | Niederer, Rebekka | Wagner, Nikolaus B. | Diem, Stefan | Berner, Fiamma | Hasan Ali, Omar | Hillmann, Dorothea | Bergamin, Irina | Joerger, Markus | Risch, Martin | Niederhauser, Christoph | Lenz, Tobias L. | Früh, Martin | Risch, Lorenz | Semela, David | Flatz, Lukas

Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC

2021 . Weber, Daniel | Decker, Miriam | Schuster, Michael | Folz, Sara | Stürmer, Carsten Johannes | Lutz, Manfred

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

2021 . Unterrainer, Marcus | Taugner, Julian | Käsmann, Lukas | Tufman, Amanda | Reinmuth, Niels | Li, Minglun | Mittlmeier, Lena M. | Bartenstein, Peter | Kunz, Wolfgang G. | Ricke, Jens | Belka, Claus | Eze, Chukwuka | Manapov, Farkhad

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

2021 . Taugner, Julian | Käsmann, Lukas | Karin, Monika | Eze, Chukwuka | Flörsch, Benedikt | Guggenberger, Julian | Li, Minglun | Tufman, Amanda | Reinmuth, Niels | Duell, Thomas | Belka, Claus | Manapov, Farkhad

Seiten